TotalMarketCap

Disc Medicine

IRONNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$3.494 B

$78.71 -5.49%

Close of 6 Nov 2026

As of 6 Nov 2026, Disc Medicine (IRON) has a market capitalization of $3.49B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$212.2M

Loss-making

Shares outstanding

45,540,842

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #64AbCellera BiologicsABCL$3.60B
  2. #65Tango TherapeuticsTNGX$3.52B
  3. #66Disc MedicineIRON$3.49B
  4. #67Amylyx PharmaceuticalsAMLX$3.48B
  5. #68Arcutis BiotherapeuticsARQT$3.42B

What if Disc Medicine were worth as much as…

Open the what-if tool →

Gold $28.2T

$636,068.14

Per share 8,081× higher

Bitcoin $1.53T

$34,416.54

Per share 437× higher

Apple $5.02T

$112,986.29

Per share 1,435× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for Disc Medicine are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.